Nuveen Asset Management, LLC Glaukos Corp Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

A detailed history of Nuveen Asset Management, LLC transactions in Glaukos Corp stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 312,298 shares of GKOS stock, worth $47.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

312,298

Previous 304,175 2.67%

Holding current value

$47.1 Million

Previous $36 Million 13.02%

% of portfolio

0.01%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$113.62 - $135.39 $922,935 - $1.1 Million	8,123 Added 2.67%	312,298 $40.7 Million
Q2 2024 Aug 09, 2024	SELL	$89.48 - $118.35 $3.15 Million - $4.16 Million	-35,186 Reduced 10.37%	304,175 $36 Million
Q1 2024 May 13, 2024	SELL	$76.4 - $96.33 $2.39 Million - $3.01 Million	-31,288 Reduced 8.44%	339,361 $32 Million
Q4 2023 Feb 14, 2024	BUY	$59.53 - $85.11 $587,620 - $840,120	9,871 Added 2.74%	370,649 $29.5 Million
Q3 2023 Nov 14, 2023	BUY	$69.23 - $79.09 $167,951 - $191,872	2,426 Added 0.68%	360,778 $27.1 Million
Q2 2023 Aug 14, 2023	BUY	$45.44 - $71.21 $10.1 Million - $15.8 Million	222,393 Added 163.57%	358,352 $25.5 Million
Q1 2023 May 15, 2023	SELL	$43.88 - $52.48 $870,272 - $1.04 Million	-19,833 Reduced 12.73%	135,959 $6.81 Million
Q4 2022 Feb 14, 2023	SELL	$40.82 - $57.75 $922,613 - $1.31 Million	-22,602 Reduced 12.67%	155,792 $6.81 Million
Q3 2022 Nov 14, 2022	BUY	$46.84 - $58.49 $1.18 Million - $1.47 Million	25,170 Added 16.43%	178,394 $9.5 Million
Q2 2022 Aug 15, 2022	BUY	$34.86 - $63.77 $395,521 - $723,534	11,346 Added 8.0%	153,224 $6.96 Million
Q1 2022 May 16, 2022	SELL	$44.33 - $57.82 $627,712 - $818,731	-14,160 Reduced 9.07%	141,878 $7.8 Million
Q4 2021 Feb 14, 2022	SELL	$40.27 - $56.99 $1.27 Million - $1.79 Million	-31,416 Reduced 16.76%	156,038 $6.93 Million
Q3 2021 Nov 12, 2021	SELL	$47.43 - $84.23 $903,114 - $1.6 Million	-19,041 Reduced 9.22%	187,454 $9.03 Million
Q2 2021 Aug 16, 2021	BUY	$73.06 - $97.7 $843,185 - $1.13 Million	11,541 Added 5.92%	206,495 $17.5 Million
Q1 2021 May 17, 2021	SELL	$70.43 - $97.42 $176,075 - $243,550	-2,500 Reduced 1.27%	194,954 $16.4 Million
Q4 2020 May 17, 2021	SELL	$48.9 - $75.26 $428,901 - $660,105	-8,771 Reduced 4.25%	197,454 $14.9 Million
Q4 2020 Feb 16, 2021	BUY	$48.9 - $75.26 $355,698 - $547,441	7,274 Added 3.66%	206,225 $15.5 Million
Q3 2020 Nov 16, 2020	SELL	$37.23 - $50.97 $5,286 - $7,237	-142 Reduced 0.07%	198,951 $9.85 Million
Q2 2020 Aug 14, 2020	BUY	$28.78 - $46.83 $89,851 - $146,203	3,122 Added 1.59%	199,093 $7.65 Million
Q1 2020 May 14, 2020	BUY	$25.53 - $70.14 $87,516 - $240,439	3,428 Added 1.78%	195,971 $6.05 Million
Q4 2019 Feb 14, 2020	BUY	$54.18 - $65.64 $813,187 - $985,190	15,009 Added 8.45%	192,543 $10.5 Million
Q3 2019 Nov 14, 2019	SELL	$58.58 - $83.91 $1.72 Million - $2.47 Million	-29,399 Reduced 14.21%	177,534 $11.1 Million
Q2 2019 Aug 15, 2019	BUY	$63.59 - $78.71 $13.2 Million - $16.3 Million	206,933 New	206,933 $15.6 Million

Others Institutions Holding GKOS

# of Institutions

341

Shares Held

46.8M

Call Options Held

132K

Put Options Held

188K

View Full List

About GLAUKOS Corp

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.18B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

More about GKOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Glaukos Corp Transaction History